Sildenafil can be a potent and selective inhibitor of cGMP-distinct phosphodiesterase kind five (PDE5), which can be accountable for degradation of cGMP from the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts being a competitive binding agent of PDE5 from the corpus cavernosum, leading to much more cGMP